China’s first self-developed mRNA vaccine to enter mass production in October with annual capacity of 200 million doses
Cyberdyne: Large contract with Hampshire Parliament in the UK: 500 million yen for HAL rental
COVID-19: Pfizer vaccine: undecided for sale in mainland China
COVID-19: Chinese vaccine: Exports surge in July
The University of Tokyo: Developed highly durable nanosheets: Reduced burden on the skin